IL-27 inhibits non-small-cell lung cancer cell metastasis by miR-935 in vitro

Onco Targets Ther. 2019 Feb 21:12:1447-1454. doi: 10.2147/OTT.S173207. eCollection 2019.

Abstract

Introduction: Non-small-cell lung cancer (NSCLC) accounts for more than half of all lung cancer cases. Cytokines play an important role in NSCLC, including IL-27. IL-27 inhibits NSCLC progression; however, the mechanism is not clear. The purpose of this study is to investigate the effects of IL-27 on NSCLC cell proliferation and metastasis.

Materials and methods: NSCLC cells were treated with IL-27 or transfected with miR-935, and the cell proliferation was assayed by Cell Counting Kit-8 (CCK-8) and colony formation. Cell metastasis was analyzed by Transwell chamber system and wound healing assay. IL-27 protein in the medium was analyzed by ELISA. IL-27 mRNA expression was measured by quantitative reverse transcriptase-PCR.

Results: We found that IL-27 played an inhibiting role in NSCLC cell proliferation and metastasis. The molecular mechanism of the suppressing role of IL-27 in NSCLC was regulated by miR-935. IL-27 expression was negatively associated with miR-935 in the clinical NSCLC samples.

Conclusion: The study revealed that IL-27 decreased lung cancer cell proliferation and metastasis via miR-935.

Keywords: IL-27; miR-935; non-small cell lung cancer.